Provided by Tiger Trade Technology Pte. Ltd.

CVRx, Inc.

2.88
+0.02000.70%
Post-market: 2.84-0.0400-1.39%19:42 EDT
Volume:1.00M
Turnover:2.81M
Market Cap:76.73M
PE:-1.46
High:2.90
Open:2.86
Low:2.75
Close:2.86
52wk High:11.30
52wk Low:2.20
Shares:26.64M
Float Shares:15.55M
Volume Ratio:1.66
T/O Rate:6.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9748
EPS(LYR):-2.0436
ROE:-133.44%
ROA:-28.70%
PB:3.85
PE(LYR):-1.41

Loading ...

CVRx's Q1 revenue rises 20%, beats expectations

Reuters
·
May 12

CVRx Q1 net loss narrows 4.7% to $13.1 million; revenue rises 20% to $14.8 million

Reuters
·
May 12

CVRx Q1 EPS $(0.50) Beats $(0.52) Estimate, Sales $14.769M Beat $14.481M Estimate.

Benzinga Earnings
·
May 12

BRIEF-CVRx Q1 Revenue USD 14.769 Million Vs. IBES Estimate USD 14.5 Million

Reuters
·
May 12

CVRx Inc - Q2 2026 Revenue Guidance $15.1-$16.1 Mln

THOMSON REUTERS
·
May 12

CVRx Inc - FY2026 Guidance: Revenue $63-$67 Mln, Gross Margin 85%-87%, Operating Expenses $103-$107 Mln

THOMSON REUTERS
·
May 12

Press Release: CVRx Reports First Quarter 2026 Financial and Operating Results

Dow Jones
·
May 12

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 11

CVRx Inc expected to post a loss of 50 cents a share - Earnings Preview

Reuters
·
May 09

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 08

Lake Street Sticks to Its Buy Rating for CVRx (CVRX)

TIPRANKS
·
May 05

CVRx enrolls first patient in BENEFIT-HF trial

TIPRANKS
·
May 05

CVRx Announces First Patient Enrollment in BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population

GlobeNewswire
·
May 05

CVRx to report first-quarter results, host conference call after market close

Reuters
·
Apr 28

CVRx to Report First Quarter 2026 Financial and Operating Results and Host Conference Call on May 11, 2026

GlobeNewswire
·
Apr 28

Press Release: CVRx Announces Nomination of Michael Dale for Election to the Board of Directors

Dow Jones
·
Apr 21

CVRx announces annual shareholder meeting

Reuters
·
Apr 21

CVRx Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Apr 14

Canaccord Genuity Remains a Buy on CVRx (CVRX)

TIPRANKS
·
Apr 14

CVRx: Strong Early Momentum, Favorable Reimbursement Tailwinds, and Compelling 2026 Valuation Support Buy Rating

TIPRANKS
·
Apr 13